Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. The company is headquartered in Niagara Falls, New York. The firm specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.
POSC stock price ended at $1.57 on 星期一, after rising 4.67%
On the latest trading day Jan 26, 2026, the stock price of POSC rose by 4.67%, climbing from $1.57 to $1.57. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $1.57 and a high of $1.57. Alongside this price increase, trading volume also rose by 532 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 181 shares were traded, amounting to a market value of approximately $49.3M.